Federated Hermes
RAPT

Federated Hermes’s RAPT Therapeutics RAPT Stock Holding History

Federated Hermes’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-136
Closed -$1.09K – 2208
2025
Q2 		$1.09K Sell
136
-25,036
-99% -$191K ﹤0.01% 1994
2025
Q1 		$246K Sell
25,172
-75,155
-75% -$739K ﹤0.01% 1463
2024
Q4 		$1.27M Buy
100,327
+330
+0.3% +$4.19K ﹤0.01% 1043
2024
Q3 		$1.61M Buy
99,997
+487
+0.5% +$9.85K ﹤0.01% 991
2024
Q2 		$2.43M Buy
99,510
+65,046
+189% +$3M 0.01% 888
2024
Q1 		$2.48M Buy
+34,464
New +$4.79M 0.01% 878
2023
Q2 		– Sell
-2,189
Closed -$321K – 2207
2023
Q1 		$321K Buy
+2,189
New +$443K ﹤0.01% 1510
2021
Q4 		– Sell
-8
Closed -$2K – 2289
2021
Q3 		$2K Buy
+8
New +$2.12K ﹤0.01% 2101
2020
Q2 		– Sell
-82
Closed -$14K – 2350
2020
Q1 		$14K Buy
+82
New +$18.7K ﹤0.01% 1829

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return